|
Oct 4
|
Capricor Therapeutics to Present Long-Term Data from HOPE-2 Open Label Extension Study at 2024 World Muscle Society Congress
|
|
Oct 3
|
Is Capricor Therapeutics, Inc. (CAPR) the Best Russell 2000 Stock to Buy According to Analysts?
|
|
Sep 26
|
High Growth Tech Stocks To Watch In September 2024
|
|
Jul 31
|
Capricor Therapeutics to Present Second Quarter 2024 Financial Results and Recent Corporate Update on August 7
|
|
Jun 25
|
CORRECTION: Capricor Therapeutics
|
|
Jun 25
|
Capricor Therapeutics Announces for the Treatment of Duchenne Muscular Dystrophy
|
|
Jun 4
|
Capricor Therapeutics Announces Positive 3-Year Efficacy Results from HOPE-2 Open Label Extension Study of CAP-1002 in Duchenne Muscular Dystrophy
|
|
May 14
|
Capricor Therapeutics Inc (CAPR) Q1 2024 Earnings Call Transcript Highlights: Strategic ...
|
|
May 13
|
Capricor Therapeutics (CAPR) Reports Q1 Loss, Misses Revenue Estimates
|
|
May 13
|
Capricor Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
|
|
May 9
|
Capricor Therapeutics to Present Exosome Platform Updates at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting
|
|
May 8
|
Capricor Therapeutics to Present at Upcoming Scientific and Medical Conferences
|
|
May 6
|
Capricor Therapeutics to Present First Quarter 2024 Financial Results and Recent Corporate Update on May 13
|
|
Apr 24
|
Here's Why We're Not Too Worried About Capricor Therapeutics' (NASDAQ:CAPR) Cash Burn Situation
|
|
Apr 24
|
Capricor Therapeutics Announces Positive Type-B Meeting with FDA for CAP-1002 Program for Duchenne Muscular Dystrophy
|
|
Apr 10
|
Wall Street Analysts Predict a 218.18% Upside in Capricor (CAPR): Here's What You Should Know
|
|
Mar 25
|
How Much Upside is Left in Capricor (CAPR)? Wall Street Analysts Think 229.15%
|
|
Mar 21
|
Capricor Therapeutics to Present at Upcoming Investor Conferences
|
|
Mar 14
|
Earnings Beat: Capricor Therapeutics, Inc. (NASDAQ:CAPR) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts
|
|
Mar 13
|
Has GSK PLC Sponsored ADR (GSK) Outpaced Other Medical Stocks This Year?
|